HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-04-15Clinical Trial Update: A Study of the Long-Term Outcomes of HIV-Positive Patients
A completed clinical trial assessing long-term outcomes in HIV-positive patients.
-
FDA approval · 2014-04-14FDA Approved: SELZENTRY — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for Selzentry (maraviroc) filed by ViiV Healthcare Company.
-
CLINICAL_TRIALS trial_result · 2014-04-14Clinical Trial Update: Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding [Phase 3]
Phase 3 trial comparing infant peri-exposure prophylaxis with Lopinavir/ritonavir versus Lamivudine to prevent HIV transmission during breas…
-
CLINICAL_TRIALS research · 2014-04-14Clinical Trial Update: Body Image in Youth With HIV
This update summarizes a completed clinical trial evaluating body image among youth with HIV, sponsored by St. Jude Children's Research Hosp…
-
CLINICAL_TRIALS trial_result · 2014-04-11Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Efavirenz in HIV-Infected Children [Phase 1, Phase 2]
Phase 1/2 trial updates report safety, tolerability, and pharmacokinetic findings for efavirenz in HIV-infected children.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-04-11Clinical Trial Update: Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in Kenya [NA]
Clinical trial in Kenya completed evaluation of discontinuing trimethoprim-sulfamethoxazole prophylaxis in adults on antiretroviral therapy.
-
CLINICAL_TRIALS trial_result · 2014-04-11Clinical Trial Update: The Effect of Hyperbilirubinemia on CV Disease, Neurocog Function and Renal Function
This completed clinical trial investigates how hyperbilirubinemia impacts cardiovascular disease, neurocognitive function, and renal functio…
-
CLINICAL_TRIALS withdrawal · 2014-04-10Clinical Trial Update: Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya [Phase 2, Phase 3]
A CDC-sponsored Phase 2/3 trial evaluating the safety and immunogenicity of influenza vaccines in HIV-infected and HIV-uninfected pregnant w…
-
CLINICAL_TRIALS trial_result · 2014-04-09Clinical Trial Update: Examining Factors That May Influence Resistance to HIV-1 Infection
A completed clinical trial sponsored by the National Institute of Allergy and Infectious Diseases examined factors that may influence resist…
-
FDA approval · 2014-04-08FDA Approved: ISENTRESS — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA has approved a supplemental application for Isentress (raltegravir) from Merck Sharp & Dohme LLC.
-
FDA approval · 2014-04-08FDA Approved: ISENTRESS — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for ISENTRESS (raltegravir) from Merck Sharp & Dohme LLC.
-
FDA approval · 2014-04-08FDA Approved: ISENTRESS — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for Isentress (raltegravir) from Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS trial_result · 2014-04-08Clinical Trial Update: Project UNITY - HIV Risk Reduction and Vaccine Education Interventions [NA]
This trial update reports the completion of the Project UNITY HIV risk reduction and vaccine education intervention study conducted by the N…
-
FDA approval · 2014-04-07FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
The FDA approved a supplemental application for PREZISTA (darunavir) submitted by Janssen Products LP.
-
FDA approval · 2014-04-07FDA Approved: APTIVUS — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for APTIVUS (tipranavir) submitted by Boehringer Ingelheim Pharmaceuticals, Inc.
-
FDA approval · 2014-04-07FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
FDA approved a supplemental application for PREZISTA (darunavir) from Janssen Products LP, resulting in updated labeling for the HIV-1 prote…
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: Home Assessment and Initiation of Antiretroviral Therapy for HIV in Malawi [NA]
Completed clinical trial in Malawi evaluating home-based assessment and initiation of antiretroviral therapy for HIV infection. Results were…
-
CLINICAL_TRIALS trial_result · 2014-04-04Clinical Trial Update: Europe-Africa Research Network for Evaluation of Second-line Therapy [Phase 3]
Phase 3 clinical trial in Europe and Africa evaluating second-line therapy for HIV infection; the study status is COMPLETED.
-
CLINICAL_TRIALS trial_result · 2014-04-04Clinical Trial Update: Effects of Motivational Interviewing on Risky Injecting Practices Among Injecting Drug Users (IDUs) [NA]
A completed clinical trial assessing the impact of motivational interviewing on risky injecting behaviors among injecting drug users, with p…
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: TMC207-TiDP13-C117: Interaction Study in Human Immunodeficiency Virus-type 1 (HIV-1) Infected Patients With Nevirapine (NVP) [Phase 1]
Phase 1 study evaluating potential drug–drug interaction between TMC207-TiDP13-C117 and nevirapine in HIV-1-infected patients; the trial has…
-
CLINICAL_TRIALS research · 2014-04-02Clinical Trial Update: ATAGLU: Study of Glucose Metabolism in HIV Positive Patients That Switch From Another Protease Inhibitor to Atazanavir [NA]
This entry describes a clinical trial evaluating glucose metabolism in HIV-positive patients who switch from another protease inhibitor to a…
-
CLINICAL_TRIALS trial_result · 2014-04-01Clinical Trial Update: Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT-TE Study [Phase 4]
Phase 4 trial evaluating two pharmacologic strategies for HIV-associated neurocognitive impairment; the study is completed and reports on ef…
-
FDA approval · 2014-03-27FDA Approved: SELZENTRY — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for Selzentry (maraviroc) submitted by ViiV Healthcare Company. The approval updates the product lab…
-
CLINICAL_TRIALS trial_result · 2014-03-27Clinical Trial Update: Dolutegravir Compared to Darunavir/Ritonavir , Each in Combination With Dual Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in ART-naive Subjects [Phase 3]
Phase 3 trial comparing dolutegravir to darunavir/ritonavir, each with dual NRTIs, in ART-naive HIV patients; completed with posted results …
-
CLINICAL_TRIALS research · 2014-03-27Clinical Trial Update: Study of Recovery of Intestinal CD4+ and Th17 T Cells in HIV-infected Individuals on Short-term Antiretroviral Therapy [NA]
A clinical trial update describing a study on the recovery of intestinal CD4+ and Th17 T cells in HIV-infected individuals during short-term…